Cargando…

Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients

Integrative Therapies (IT), otherwise known as Complementary and Alternative Medicine, are widely used among pediatric oncology patients, despite a paucity of available evidence. This review summarizes surveys that describe the prevalence of IT use by pediatric oncology patients, both during therapy...

Descripción completa

Detalles Bibliográficos
Autor principal: Jacobs, Shana S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928739/
https://www.ncbi.nlm.nih.gov/pubmed/27417488
http://dx.doi.org/10.3390/children1030424
_version_ 1782440482969747456
author Jacobs, Shana S
author_facet Jacobs, Shana S
author_sort Jacobs, Shana S
collection PubMed
description Integrative Therapies (IT), otherwise known as Complementary and Alternative Medicine, are widely used among pediatric oncology patients, despite a paucity of available evidence. This review summarizes surveys that describe the prevalence of IT use by pediatric oncology patients, both during therapy and in survivorship, as well as the modalities being used. Additionally, the evidence that exists for specific treatments that appear to be efficacious in controlling specific symptoms is described. Finally, there are recommendations for practitioners on how to best counsel patients about IT use.
format Online
Article
Text
id pubmed-4928739
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49287392016-07-12 Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients Jacobs, Shana S Children (Basel) Review Integrative Therapies (IT), otherwise known as Complementary and Alternative Medicine, are widely used among pediatric oncology patients, despite a paucity of available evidence. This review summarizes surveys that describe the prevalence of IT use by pediatric oncology patients, both during therapy and in survivorship, as well as the modalities being used. Additionally, the evidence that exists for specific treatments that appear to be efficacious in controlling specific symptoms is described. Finally, there are recommendations for practitioners on how to best counsel patients about IT use. MDPI 2014-11-14 /pmc/articles/PMC4928739/ /pubmed/27417488 http://dx.doi.org/10.3390/children1030424 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jacobs, Shana S
Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients
title Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients
title_full Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients
title_fullStr Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients
title_full_unstemmed Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients
title_short Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients
title_sort integrative therapy use for management of side effects and toxicities experienced by pediatric oncology patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928739/
https://www.ncbi.nlm.nih.gov/pubmed/27417488
http://dx.doi.org/10.3390/children1030424
work_keys_str_mv AT jacobsshanas integrativetherapyuseformanagementofsideeffectsandtoxicitiesexperiencedbypediatriconcologypatients